GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (XCNQ:AWKN) » Definitions » Asset Turnover

Awakn Life Sciences (XCNQ:AWKN) Asset Turnover : 0.01 (As of Oct. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Awakn Life Sciences's Revenue for the three months ended in Oct. 2024 was C$0.00 Mil. Awakn Life Sciences's Total Assets for the quarter that ended in Oct. 2024 was C$0.78 Mil. Therefore, Awakn Life Sciences's Asset Turnover for the quarter that ended in Oct. 2024 was 0.01.

Asset Turnover is linked to ROE % through Du Pont Formula. Awakn Life Sciences's annualized ROE % for the quarter that ended in Oct. 2024 was 97.47%. It is also linked to ROA % through Du Pont Formula. Awakn Life Sciences's annualized ROA % for the quarter that ended in Oct. 2024 was -191.96%.


Awakn Life Sciences Asset Turnover Historical Data

The historical data trend for Awakn Life Sciences's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Asset Turnover Chart

Awakn Life Sciences Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Asset Turnover
- 0.06 - 0.04

Awakn Life Sciences Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.03 0.06 0.02 0.01

Competitive Comparison of Awakn Life Sciences's Asset Turnover

For the Biotechnology subindustry, Awakn Life Sciences's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's Asset Turnover falls into.



Awakn Life Sciences Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Awakn Life Sciences's Asset Turnover for the fiscal year that ended in Jan. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Jan. 2024 )/( (Total Assets (A: Jan. 2023 )+Total Assets (A: Jan. 2024 ))/ count )
=0.087/( (4.394+0.543)/ 2 )
=0.087/2.4685
=0.04

Awakn Life Sciences's Asset Turnover for the quarter that ended in Oct. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Oct. 2024 )/( (Total Assets (Q: Jul. 2024 )+Total Assets (Q: Oct. 2024 ))/ count )
=0.004/( (0.898+0.669)/ 2 )
=0.004/0.7835
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Awakn Life Sciences  (XCNQ:AWKN) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Awakn Life Sciences's annulized ROE % for the quarter that ended in Oct. 2024 is

ROE %**(Q: Oct. 2024 )
=Net Income/Total Stockholders Equity
=-1.504/-1.543
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-1.504 / 0.016)*(0.016 / 0.7835)*(0.7835/ -1.543)
=Net Margin %*Asset Turnover*Equity Multiplier
=-9400 %*0.0204*-0.5078
=ROA %*Equity Multiplier
=-191.96 %*-0.5078
=97.47 %

Note: The Net Income data used here is four times the quarterly (Oct. 2024) net income data. The Revenue data used here is four times the quarterly (Oct. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Awakn Life Sciences's annulized ROA % for the quarter that ended in Oct. 2024 is

ROA %(Q: Oct. 2024 )
=Net Income/Total Assets
=-1.504/0.7835
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-1.504 / 0.016)*(0.016 / 0.7835)
=Net Margin %*Asset Turnover
=-9400 %*0.0204
=-191.96 %

Note: The Net Income data used here is four times the quarterly (Oct. 2024) net income data. The Revenue data used here is four times the quarterly (Oct. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Awakn Life Sciences Asset Turnover Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling it to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences Headlines

No Headlines